This protocol explains how to measure the effect of genetic variation associated with neurodevelopmental disorders on deubiquitylating enzyme activity by combining recombinant protein purification with ubiquitin chain cleavage assays.
ACERCA DE JoVE
Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados